The featured products include compounded products which have not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs.

Compounded semaglutide offered by InstaRX has not been evaluated or approved by the FDA for safety, efficacy, or quality.

Wegovy® (semaglutide) and Ozempic® (semaglutide) are not compounded products. Wegovy® is FDA-approved for weight loss, while Ozempic® is FDA-approved for type 2 diabetes but may be prescribed off-label for weight loss at a provider’s discretion.

A healthcare provider may prescribe a compounded medication if it is deemed medically appropriate and necessary for your treatment.